Editorial Commentary: Shoulder Minimal Clinically Important Difference and Patient Acceptable Symptomatic State Metrics Provide a Foundation for Interpreting Patient-Reported Outcomes.

IF 4.4 1区 医学 Q1 ORTHOPEDICS
Robert Z Tashjian
{"title":"Editorial Commentary: Shoulder Minimal Clinically Important Difference and Patient Acceptable Symptomatic State Metrics Provide a Foundation for Interpreting Patient-Reported Outcomes.","authors":"Robert Z Tashjian","doi":"10.1016/j.arthro.2024.09.045","DOIUrl":null,"url":null,"abstract":"<p><p>Limited data have been previously published on the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS) after the treatment of shoulder instability. The MCID and PASS are useful in understanding how well one treatment performs against another and whether the differences in outcomes between treatments are clinically important to patients, supporting either treatment, performing power calculations for clinical studies and trials, and making an assessment as to whether a patient's final clinical state after treatment is reasonable. Anchor-based and distribution methods of MCID calculation have been performed for a variety of patient-reported outcome measures after the treatment of shoulder instability. In general, there is a high degree of variability in the MCID and PASS metrics reported in a relatively limited number of studies. Because of the importance of these metrics in interpreting clinical data, an emphasis should be placed on improved research to further define these metrics, along with others including substantial clinical benefit and maximal outcome improvement, for a variety of different shoulder instability pathologies as well as treatments. Nevertheless, the initial set of MCID and PASS metrics published provides a solid foundation for interpreting patient-reported outcome measures in the treatment of shoulder instability.</p>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":" ","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arthro.2024.09.045","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Limited data have been previously published on the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS) after the treatment of shoulder instability. The MCID and PASS are useful in understanding how well one treatment performs against another and whether the differences in outcomes between treatments are clinically important to patients, supporting either treatment, performing power calculations for clinical studies and trials, and making an assessment as to whether a patient's final clinical state after treatment is reasonable. Anchor-based and distribution methods of MCID calculation have been performed for a variety of patient-reported outcome measures after the treatment of shoulder instability. In general, there is a high degree of variability in the MCID and PASS metrics reported in a relatively limited number of studies. Because of the importance of these metrics in interpreting clinical data, an emphasis should be placed on improved research to further define these metrics, along with others including substantial clinical benefit and maximal outcome improvement, for a variety of different shoulder instability pathologies as well as treatments. Nevertheless, the initial set of MCID and PASS metrics published provides a solid foundation for interpreting patient-reported outcome measures in the treatment of shoulder instability.

肩部 MCID 和 PASS 指标为解释患者报告的结果提供了基础。
关于肩关节不稳治疗后的最小临床意义差异(MCID)和患者可接受症状状态(PASS),此前发表的数据有限。最小临床意义差异(MCID)和患者可接受症状状态(PASS)有助于了解一种治疗方法对另一种治疗方法的效果如何,以及不同治疗方法的效果差异对支持其中一种治疗方法的患者是否具有临床意义,还有助于为临床研究和试验进行功率计算,并评估患者治疗后的最终临床状态是否合理。在治疗肩关节不稳定后,对患者报告的各种结果指标进行了基于锚点和分布的 MCID 计算方法。一般来说,在数量相对有限的研究中,MCID 和 PASS 指标的变异性很大。鉴于这些指标在解释临床数据方面的重要性,应重点加强研究,进一步明确这些指标以及其他指标,包括针对各种不同肩关节不稳定病理和治疗方法的实质性临床获益(SCB)和最大疗效改善(MOI)。尽管如此,最初公布的一组 MCID 和 PASS 指标为解释肩关节不稳定治疗中的患者报告结果指标奠定了坚实的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.30
自引率
17.00%
发文量
555
审稿时长
58 days
期刊介绍: Nowhere is minimally invasive surgery explained better than in Arthroscopy, the leading peer-reviewed journal in the field. Every issue enables you to put into perspective the usefulness of the various emerging arthroscopic techniques. The advantages and disadvantages of these methods -- along with their applications in various situations -- are discussed in relation to their efficiency, efficacy and cost benefit. As a special incentive, paid subscribers also receive access to the journal expanded website.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信